can tirzepatide cause gallstones (a glucagon-like peptide-1 receptor agonist) cholecystitis in the context of rapid weight loss? GLP-1 Medications and Gallstones: Safety

Blood pressure should also be tracked regularly, especially since weight loss may require adjustments to your medications

It is available as a once-daily oral tablet and requires a prescription

Yesin a study published in Endocrine Practice, people who switched directly from a GLP-1 treatment (including semaglutide) to tirzepatide at 5 mg saw improved blood sugar control and additional weight loss within 12 weeks, with milder digestive side effects that typically seen in patients starting tirzepatide for the first time

This is a separate coverage door from the weight-loss indication and has been available since the March 2024 FDA approval